期刊文献+

闽南地区人群中HLA-B* 5801基因频率的分析 被引量:3

Analysis of frequency of HLA-B* 5801 in population of Chinese Minnan region
下载PDF
导出
摘要 目的:了解闽南地区人群中HLA-B*5801的基因频率,探讨筛查HLA-B*5801的必要性。方法:本研究选取闽南地区178名需服用别嘌呤醇的患者(痛风患者40例,高尿酸血症患者89例和痛风性关节炎患者49例)和100名健康人,从全血中提取DNA,采用实时荧光PCR技术(Real-time PCR)和碱基序列测序(SBT)技术对所有DNA样本进行测定。结果:通过检测发现有22%的患者及16%的健康人含有HLA-B*5801,在患者中HLA-B*5801的基因频率为0.13,在健康人中为0.09,PCR法与SBT法检测结果一致。结论:闽南地区人群中HLA-B*5801的基因频率较高,因此需服用别嘌呤醇的患者在服药前有必要进行HLA-B*5801的筛查。 Objective: To investigate the gene frequency of HLA-B* 5801 in the population of Chinese Minnan region. Methods: In this study, we enrolled 178 patients requiring allopurinol therapy( including 40 patients with gout,89 patients with hyperuricemia and 49 patients with gouty arthritis) and 100 healthy people. We isolated genomie DNA from their blood and screened for HLA-B * 5801 with both PCR and gene sequencing. Results: We found 22% patients and 16% healthy people with HLA-B * 5801. The frequencies of HLA-B * 5801 in patients and healthy people are 0. 13 and 0. 09, respectively. The results from PCR and gene sequencing were consistent. Conclusion: The frequency of HLA-B * 5801 in the population of Chinese Minnan region is relatively high. Therefore,it is necessary to screen for HLA-B * 5801 in allopurinol users before taking the medicine.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2015年第5期663-666,共4页 Chinese Journal of Immunology
基金 国家自然科学基金(81302529) 福建省自然科学基金(2014D007)资助
关键词 闽南地区 HLA-B*5801 基因频率 Chinese Minnan region HLA-B * 5801 Gene frequency
  • 相关文献

参考文献8

  • 1王青,梅虎,张亚兰,潘显超,谭文,晁丽.遗传异质性药物毒副作用与HLA基因关联及分子机制研究进展[J].药学学报,2013,48(6):799-808. 被引量:6
  • 2Hung SI, Chung WH, Liou LB, et al. HLA-B * 5801 allele as a genetic marker for severe cutaneous adverse reactions caused by al- lopurinol E J ]. Proc Natl Acad Sci USA ,2005,102:4134-4319.
  • 3Chiu ml,Hu M,Ng MH,et al. Association between HLA-B * 58: 01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hang Kong [J]. Br J Dermatol,2012,167:44-49.
  • 4Lee MH, Stocker SL, Williams KM,et al. HLA-B * 5801 should be used to screen for risk of Stevens-Johnson syndrome in family members of Han Chinesepatients commencing allopurinol therapy [ J]. J Rheumato1,2013 ,40 :96-97.
  • 5Lonjou C,Borot N,Sekula P,et ul. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs [ J]. Pbermacogenet Genomics, 2008, 18: 99-107.
  • 6Tohkin M, Kaniwa N, Saito Y, eta/. A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal neerolysis in Japanese patients [ J]. Phannacogenomics J,2013,13 ( 1 ) :60-69.
  • 7Tassaneeyakul W, Jantararoungtong T, Chen P, et al. Strong association between HLA-B* 5801 and aUopurinol-induced Stevens-Johnson syndrome and toxic epidermal neerolysis in a Thai population I J ]. Pharmaeogenet Genomics,2009 ,19 :704-709.
  • 8Kang HR,Jee YK,Kim YS ,et al. Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans [ J ]. Pharmacogenet Genomlcs ,2011,21:303-307.

二级参考文献2

共引文献5

同被引文献16

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部